A media briefing with experts from the Infectious Diseases Society of America to discuss coronavirus and COVID-19 developments and answer questions.
Topical Agenda for December 3 Briefing:
IDSA experts will discuss COVID-19 vaccines currently being studied:
- Differences between vaccine types
- Efficacy, safety profiles, and unknowns
- COVID-19 vaccine development and research process
- Questions from media
FEATURING:
C. Buddy Creech, MD, MPH, FPIDS—Nashville, TN
Member, Infectious Diseases Society of America
Director, Vanderbilt Vaccine Research Program
Principal Investigator, Phase III trial for SARS-CoV-2 vaccine (Moderna)
Principal Investigator, Phase III trial for SARS-CoV-2 vaccine (Johnson & Johnson)
Kathleen M. Neuzil, MD, MPH, FIDSA—Baltimore, MD
Fellow, Infectious Diseases Society of America
Director, Center for Vaccine Development and Global Health
Myron M. Levine Professor in Vaccinology, University of Maryland School of Medicine
Co-Director, COVID-19 Prevention Network, the NIH network of sites engaged in the trials
Chris Busky, CAE (Moderator)
Chief Executive Officer—Infectious Diseases Society of America
